Clinical News

UK IBD Registry ends year on a high note

Wednesday, 21 December 2016 14:26

We approach the end of the year with 60 sites actively participating in the IBD Registry, and over 21,000 patient records submitted. 80 sites in total have a 'live' system for data capture, and 21 additional sites are in the process of setting up, so we expect patient numbers to increase steadily.

Members of the Registry's industry working group have generously contributed to a fund specifically to support sites with data entry. For more information please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it by 20th January 2017.

Many thanks to our colleagues at AbbVie, Allergan, Dr Falk, Janssen, Napp, Pfizer, Takeda, Tillotts and Vifor for their contributions to this fund. If you have not yet registered to participate in the IBD Registry, would like help uploading your data, or have any other registry related queries please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

*Grants may be higher depending on the number of sites applying.


New metrics for the Lancet Standing Commission on Liver Disease in the UK

Friday, 16 December 2016 12:41

The format for this third report of the Lancet Commission follows the same pattern as in 2015 in concentrating on the main recommendations, all of which are evidence based and have been most carefully considered in terms of their ability to reduce the current burden of liver disease in the UK and its financial cost. The working groups set up around the recommendations have concentrated this year on producing a set of the main metrics, which will enable further charting of disease prevalence and consequences on an annual basis.

GIRFT - An opportunity to make a difference to your specialty at a national level

Thursday, 08 December 2016 15:24

Following the success of Getting It Right First Time's (GIRFT) orthopaedic pilot, which has already seen surgeons changing practice to improve quality and reduce unwanted variation, the Secretary of State for Health has announced extended funding to roll out the innovative programme led by Professor Tim Briggs, National Director of Clinical Quality and Efficiency, within its new home at NHS Improvement. This work forms a key part of the roll-out of the recommendations in Lord Carter's report (February 2016) in operational performance and productivity in acute hospitals. The programme is expanding from 11 to 29 clinical work-streams including three additional surgical specialties. Professor Briggs will be working closely with Professor Tim Evans, National Director of Clinical Productivity, to deliver the programme across a range of clinical work-streams.

To be led by some of the nation's most well-regarded surgeons and physicians, this is an opportunity to deliver a real difference to the delivery of care for the many patients who access NHS care. GIRFT will improve the quality of care across surgical and medical specialties and reduce complications and unwanted variation. Further it will enable less to be spent on unnecessary treatments, patients will spend less time in hospital and clinicians will be freed up to provide more care - all of this equal to £1.5bn of health service costs each year.

The Clinical Leads will oversee the creation of a national review of all data using the proven GIRFT methodology relating to the delivery of their specialty across England. Providers will be benchmarked against one another and best practice, with each trust receiving a comprehensive review of their data and receiving support to tackle the challenges and findings behind the variation that the review highlights. The role will involve close collaborative working with National Clinical Directors and Specialised Commissioning Clinical Reference Group Chairs within NHS England where they are in place, and also with speciality leads where they exist within the Medical Directorate of NHS Improvement.

The programme is looking for skilled and effective clinical leaders who are recognised as experts by their clinical colleagues and have the endorsement of their specialty societies, who have been consulted extensively during the development of this phase of the programme. The roles are an exciting opportunity to make a contribution to the shaping of the service nationally, engaging with stakeholders across the specialty and the country. They will be on a part time secondment basis over an initial two-year period and we anticipate an average commitment of 88 days per year.

Closing date: Sunday 5th February 2017

Chair of the Research Advisory Committee on PHE Screening

Thursday, 01 December 2016 13:27

Public Health England are currently advertising for three Chairs for Public Health England’s cancer screening programme Research Advisory Committees (RAC). One for each of the below RACs:

  • Bowel Cancer Screening Programme (BCSP)
  • Breast Screening Programme (BSP)
  • Cervical Screening Programme (CSP)

The RACs are responsible for ensuring that PHEs screening programmes support good quality research without compromising the day to day function of the screening programmes. Candidates should be able to demonstrate experience in one or more of the following:

  • Experience in chairing a multidisciplinary group.
  • A detailed understanding of screening.
  • Experience in health services research (ideally in screening programmes).

Closing date: 07/12/2016


Page 8 of 16